PL2032593T3 - Pochodne aminowe B-homoandrostanów i B-heteroandrostanów - Google Patents

Pochodne aminowe B-homoandrostanów i B-heteroandrostanów

Info

Publication number
PL2032593T3
PL2032593T3 PL07729767T PL07729767T PL2032593T3 PL 2032593 T3 PL2032593 T3 PL 2032593T3 PL 07729767 T PL07729767 T PL 07729767T PL 07729767 T PL07729767 T PL 07729767T PL 2032593 T3 PL2032593 T3 PL 2032593T3
Authority
PL
Poland
Prior art keywords
homoandrostanes
heteroandrostanes
amino derivatives
derivatives
amino
Prior art date
Application number
PL07729767T
Other languages
English (en)
Inventor
Alberto Cerri
Barbara Moro
Maco Torri
Giulio Carzana
Giuseppe Bianchi
Mara Ferrandi
Patrizia Ferrari
Maria Pia Zappavigna
Leonardo Banfi
Giuseppe Giacalone
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PL2032593T3 publication Critical patent/PL2032593T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/004—Expansion of ring B by one atom, e.g. B homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PL07729767T 2006-06-23 2007-05-31 Pochodne aminowe B-homoandrostanów i B-heteroandrostanów PL2032593T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06116001 2006-06-23
PCT/EP2007/055366 WO2007147713A1 (en) 2006-06-23 2007-05-31 Amino derivatives of b-homoandrostanes and b-heteroandrostanes
EP07729767A EP2032593B1 (en) 2006-06-23 2007-05-31 Amino derivatives of b-homoandrostanes and b-heteroandrostanes

Publications (1)

Publication Number Publication Date
PL2032593T3 true PL2032593T3 (pl) 2011-05-31

Family

ID=37603055

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07729767T PL2032593T3 (pl) 2006-06-23 2007-05-31 Pochodne aminowe B-homoandrostanów i B-heteroandrostanów

Country Status (21)

Country Link
US (1) US8022203B2 (pl)
EP (1) EP2032593B1 (pl)
JP (1) JP4664433B2 (pl)
KR (1) KR101446166B1 (pl)
CN (1) CN101479291B (pl)
AR (1) AR061561A1 (pl)
AT (1) ATE497504T1 (pl)
AU (1) AU2007263117B2 (pl)
BR (1) BRPI0713439A2 (pl)
CA (1) CA2654354C (pl)
CY (1) CY1112012T1 (pl)
DE (1) DE602007012348D1 (pl)
DK (1) DK2032593T3 (pl)
EA (1) EA014333B1 (pl)
ES (1) ES2359544T3 (pl)
HK (1) HK1134097A1 (pl)
MX (1) MX2008016425A (pl)
PL (1) PL2032593T3 (pl)
SI (1) SI2032593T1 (pl)
TW (1) TWI372762B (pl)
WO (1) WO2007147713A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5323063B2 (ja) * 2007-05-31 2013-10-23 塩野義製薬株式会社 オキシイミノ化合物およびその使用
JP5450387B2 (ja) * 2008-04-02 2014-03-26 株式会社カネカ （ｓ）−３−（１−シアノ−１，１−ジフェニルメチル）−ピロリジンの製造法
EP2346820B1 (en) 2008-06-11 2013-02-13 Shionogi & Co., Ltd. Oxycarbamoyl compounds and the use thereof
US20120028945A1 (en) * 2009-03-23 2012-02-02 Patrizia Ferrari 5-Beta, 14-Beta-Androstane Derivatives Useful For The Treatment Of Proteinuria, Glomerulosclerosis And Renal Failure
GB201104199D0 (en) 2011-03-11 2011-04-27 Syngenta Participations Ag Plant growth regulator compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2806029A (en) * 1956-07-16 1957-09-10 Searle & Co 3-oxygenated 12a-aza-c-homopregnane-12, 20-diones and congeners
US3136584A (en) * 1963-01-25 1964-06-09 Whitlock Associates Inc Bulk material hopper unloader
US3328408A (en) * 1964-01-30 1967-06-27 Smith 6-azaestranes, intermediates and process
DE19633349A1 (de) 1996-08-19 1998-02-26 Sigma Tau Ind Farmaceuti Neue 6-Hydroxy- und 6-Oxo-androstan-Derivate, die auf das kardiovaskuläre System wirken und pharmazeutische Zusammensetzungen, die diese enthalten
US6825208B2 (en) * 2001-08-20 2004-11-30 Bristol-Myers Squibb Pharma Company Tetrahydroquinoline derivatives as antithrombotic agents
US7053076B2 (en) * 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
CA2571409C (en) * 2004-06-24 2012-01-24 Wisconsin Alumni Research Foundation Neoglycorandomization and digitoxin analogs

Also Published As

Publication number Publication date
AU2007263117A1 (en) 2007-12-27
US8022203B2 (en) 2011-09-20
AU2007263117A2 (en) 2009-03-12
CY1112012T1 (el) 2015-11-04
SI2032593T1 (sl) 2011-05-31
CA2654354A1 (en) 2007-12-27
WO2007147713A1 (en) 2007-12-27
CA2654354C (en) 2014-12-23
US20090209506A1 (en) 2009-08-20
TW200817427A (en) 2008-04-16
JP2009541410A (ja) 2009-11-26
CN101479291B (zh) 2012-09-19
EA200970046A1 (ru) 2009-06-30
TWI372762B (en) 2012-09-21
JP4664433B2 (ja) 2011-04-06
AR061561A1 (es) 2008-09-03
EP2032593A1 (en) 2009-03-11
AU2007263117B2 (en) 2012-05-24
DE602007012348D1 (de) 2011-03-17
HK1134097A1 (pl) 2010-04-16
EA014333B1 (ru) 2010-10-29
ATE497504T1 (de) 2011-02-15
ES2359544T3 (es) 2011-05-24
KR20090023730A (ko) 2009-03-05
KR101446166B1 (ko) 2014-10-01
CN101479291A (zh) 2009-07-08
MX2008016425A (es) 2009-01-21
BRPI0713439A2 (pt) 2012-03-06
DK2032593T3 (da) 2011-05-16
EP2032593B1 (en) 2011-02-02

Similar Documents

Publication Publication Date Title
HK1254895A1 (zh) 苄基苯衍生物及使用方法
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
EP2054063A4 (en) 4-AMINOCHINAZOLINE DERIVATIVES AND METHOD FOR THEIR USE
EP2120965A4 (en) N-HALOGENATED AMINO BINDINGS AND DERIVATIVES
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
ZA200808757B (en) Pyrrole derivatives and their methods of use
IL220270A0 (en) Polymyxin derivatives and uses thereof
EP1843661A4 (en) COMPOSITIONS COMPRISING O-ACETYLSALICYL DERIVATIVES OF AMINO ACID AND AMINO ACIDS
EP2023718A4 (en) CREATINLIGATE COMPOUNDS AND APPLICATION METHOD THEREFOR
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
IL197501A0 (en) Modifications of cupredoxin derived peptides and methods of use thereof
ZA200808017B (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
ZA200807614B (en) Buprenorphine derivatives and uses thereof
IL192427A0 (en) Derivatives of sulindac, use thereof and preparation thereof
IL196594A0 (en) Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
EP2099299A4 (en) OXAZOLIDINONE DERIVATIVES AND METHOD FOR THEIR USE
EP2077262A4 (en) IMINOPYRIDINE DERIVATIVES AND THEIR USE
EP2245020A4 (en) DERIVATIVES OF THIAZOLYLIDINE UREA AND AMIDES AND METHODS OF USE THEREOF
EP1946007A4 (en) ANDROSTERONE DERIVATIVES AND METHODS OF USE
GB0605295D0 (en) Amino and derivatives
TWI372762B (en) Amino derivatives of b-homoandrostanes and b-heteroandrostanes
EP1845984A4 (en) METHYLPHENIDATE DERIVATIVES AND THEIR USES
IL196320A0 (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
ZA200900960B (en) Arylpiperazine derivatives and uses thereof